Clinical Trials Browser

Interventional × Gastrointestinal Neoplasms × camrelizumab × Clear all

NCT02742935 2023-02-27

A Study to Evaluate the Safety and Tolerability of Using SHR-1210 by Advanced Solid Tumor Subjects

Phase 1 Completed

BreastGastrointestinal

Breast Neoplasms, Gastrointestinal Neoplasms

NCT05225844 2022-02-07

An Exploratory Trail of Camrelizumab Plus Apatinib Mesylate for Advanced Gastrointestinal

Phase 2 Unknown

Gastrointestinal

Gastrointestinal Neoplasms